Zio XT ECG Monitoring System vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS

AI Verdict

Tool A, the Zio XT ECG Monitoring System, is primarily designed for continuous, extended ECG monitoring (up to 14 days) with expert review, focusing on arrhythmia diagnosis in clinical practice. Tool B, the Verily Study Watch, offers on-demand ECG and irregular pulse monitoring along with other physiological data collection, positioning it more broadly for clinical research and general healthcare use. While both provide cardiac monitoring, Zio XT is tailored for a dedicated diagnostic workflow, whereas the Study Watch emphasizes broader data collection for research and prescription-based applications.

Choose Zio XT ECG Monitoring System if…

Choose Zio XT if your clinical objective is to achieve a definitive diagnosis of intermittent arrhythmias through continuous, high-compliance ECG monitoring for up to 14 days. Its leadless, water-resistant design ensures patient comfort and adherence, making it ideal for detecting elusive cardiac events in a real-world setting.

View Zio XT ECG Monitoring System →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch if your project involves clinical research or specialized healthcare applications requiring comprehensive physiological and environmental data collection beyond just continuous ECG. This prescription-only device is best suited for studies investigating correlations between on-demand ECG, irregular pulse, activity, and other contextual factors over an extended period.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio XT ECG Monitoring System Study Watch with Irregular Pulse Monitor (Home)
Pricing Contact for pricing Unknown
Deployment Cloud-based (AWS EC2 platform), no on-premise hardware required. Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Unknown
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Tool A emphasizes patient comfort with a wire-free, water-resistant design for daily activities, leading to high reported compliance and satisfaction. Tool B, while designed to be unobtrusive, focuses on 'on-demand' ECG and clinical research, which may imply less emphasis on broad patient ease of use for routine, continuous monitoring.

Clinical Value

Zio XT ECG Monitoring System

Tool A provides continuous cardiac monitoring for up to 14 days with FDA-cleared AI and expert review specifically for accurate arrhythmia detection and diagnosis, offering a clear diagnostic pathway. Tool B offers broader physiological and environmental data, but its ECG is 'on-demand' and its primary use case is clinical research, potentially offering less comprehensive diagnostic data for continuous arrhythmia detection in routine clinical practice.

Pricing & Value

Zio XT ECG Monitoring System

Tool A offers transparent pricing details for both the UK and US markets, including established CPT codes for reimbursement, indicating a clear value proposition for clinical adoption. Tool B's pricing is not publicly available and is primarily for clinical research and prescription use, making its value for standard clinical practice difficult to assess.

Enterprise Readiness

Zio XT ECG Monitoring System

Tool A demonstrates strong enterprise readiness with explicit HIPAA compliance, a Business Associate Agreement (BAA), and deployment on a robust cloud platform (AWS EC2). While Tool B also claims HIPAA compliance and a BAA, the reported lawsuit alleging past HIPAA breaches introduces a potential concern regarding its long-term enterprise trust and data security posture.

Innovation

Study Watch with Irregular Pulse Monitor (Home)

Tool B shows greater innovation by integrating a wider array of physiological and environmental sensors beyond just ECG, offering a more comprehensive and multi-modal approach to health data collection. While Tool A excels in extended continuous ECG monitoring with FDA-cleared AI, Tool B's broader sensing capabilities suggest more expansive future applications in health data capture.

Support & Docs

Zio XT ECG Monitoring System

Tool A explicitly highlights 'full support' for products, billing, and services, including a 24/7/365 specialized billing team and dedicated customer care lines for patients and professionals. Tool B provides various documentation and resources for its data platforms and regulatory information, but the direct, comprehensive, and always-available support for patients and billing, as offered by Tool A, appears more robust for a widely deployed clinical diagnostic service.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio XT ECG Monitoring System Study Watch with Irregular Pulse Monitor (Home)
Device Name Zio XT ECG Monitoring System Study Watch with Irregular Pulse Monitor (Home)
Company iRhythm Technologies Verily Life Sciences LLC
Monitoring Duration Up to 14 days continuous Not specified
ECG Type Wearable single-lead ECG biosensor On-demand single-channel ECG measurement
Key Feature 1 Continuous ambulatory cardiac monitoring for up to 14 days Irregular pulse monitoring for atrial fibrillation (AFib) detection
Key Feature 2 Water-resistant design for normal daily activities, including showering Multiple physiological sensors (heart rate, electrodermal activity, inertial movements)
Key Feature 3 Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis Long battery life (up to one week)

Videos

Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio XT ECG Monitoring System offers continuous ambulatory cardiac monitoring for up to 14 days using a wearable single-lead ECG biosensor. In contrast, the Verily Study Watch with Irregular Pulse Monitor (Home) provides on-demand single-channel ECG measurements and irregular pulse monitoring for atrial fibrillation (AFib) detection, with a battery life of up to one week.
The Zio XT system is primarily designed for accurate arrhythmia detection and diagnosis through continuous ECG monitoring for symptomatic and asymptomatic patients. The Verily Study Watch focuses on irregular pulse monitoring for AFib detection and collecting various physiological and environmental data for clinical research and healthcare use.
The Zio XT biosensor is water-resistant and features no external leads or wires, allowing patients to continue normal daily activities, including showering, which contributes to high patient compliance. The Verily Study Watch is described as an unobtrusive wearable device designed for data collection, with a focus on real-time monitoring on the wrist.
The Zio XT system utilizes a proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis, with results reviewed by certified cardiographic technicians. The Verily Study Watch employs cloud-based data processing with proprietary algorithms and machine learning, including a deep neural network algorithm trained on real-world data for AFib detection.

Backers

Who funded each tool's parent company.

Study Watch with Irregular Pulse Monitor (Home)

AI Tool Finder
AI-powered search. Results may not be comprehensive.